equity awards

Cue Biopharma grants inducement equity to new President and CEO Dr. Shao-Lee Lin and six employees under Nasdaq rules, signaling leadership transition and growth strategy.

SCYNEXIS grants 125,000 stock options at $0.93/share and 20,000 RSUs to new VP under Nasdaq inducement rules.

Zentalis Pharmaceuticals granted 36,000 stock options at $2.57/share to two new hires under Nasdaq inducement rules, vesting over four years.

Damora Therapeutics appoints Jennifer Jarrett as CEO, grants her 2M share awards. Company also awards equity to four new employees under Nasdaq inducement rules.

Elutia grants 460,000 non-qualified stock options to three new employees at $1.09 exercise price with four-year vesting under Nasdaq inducement rules.

Tango Therapeutics grants new employee 367,500 stock options and 60,000 RSUs valued at $11.94 exercise price under inducement plan.

Penguin Solutions awards equity package including RSUs and performance-based PSUs to new Chief Product Officer, signaling strategic investment in product leadership.

Perpetua Resources executive sells $1.21M in shares for tax obligations amid 332% annual surge and upcoming earnings.